Elon Musk announced that Neuralink plans to significantly increase production of brain-chip implants in 2026, with an almost fully automated surgical procedure to implant the devices, aiming to help patients with neurological conditions and potentially merge human consciousness with AI.
Gabe Newell, founder of Valve, is investing in Starfish Neuroscience, a startup developing advanced brain-computer interface chips aimed at medical applications like disease therapy, with products expected to launch in late 2025 and seeking collaborators in related fields.
Blackrock Neurotech, a biotech company in Utah, has implanted brain chips in over 50 people, curing various ailments and disabilities, beating Elon Musk's Neuralink, which is still waiting for FDA approval to start testing on humans. The NeuroPort Array chip enables individuals to control robotic limbs and wheelchairs, play video games, and even sense feelings. Blackrock is seeking FDA approval for devices designed for use outside of the lab, such as those used by people with paralysis at home. The company is already working on brain-computer connections that will help restore hearing and vision.